Vineet Agarwal
Geen lopende functies
Vermogen: - $ op 30-04-2024
Profiel
Vineet Agarwal is currently the Chief Financial Officer at Korro Bio, Inc. (United States) since 2021.
He is also the Treasurer, Chief Financial & Accounting Officer at Korro Bio, Inc. since 2023.
Previously, he worked as the Executive Director-Biotech Investment Banking at 09143628 Ltd.
from 2019 to 2021.
He also held the position of Executive Director at JPMorgan Chase & Co. from 2019 to 2021.
Mr. Agarwal holds an MBA from the Institute of Management Technology and an undergraduate degree from Shri Ram College of Commerce.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 17-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Vineet Agarwal
| Bedrijven | Functie | Begin |
|---|---|---|
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Financieel Directeur/CFO | 01-05-2021 |
Eerdere bekende functies van Vineet Agarwal
| Bedrijven | Functie | Einde |
|---|---|---|
| 09143628 Ltd. | Corporate Officer/Principal | 01-05-2021 |
| JPMORGAN CHASE & CO. | Directeur/Bestuurslid | 01-05-2021 |
Opleiding van Vineet Agarwal
| Institute of Management Technology | Masters Business Admin |
| Shri Ram College of Commerce | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| JPMORGAN CHASE & CO. | Finance |
| Bedrijven in privébezit | 2 |
|---|---|
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Health Technology |
| 09143628 Ltd. | Finance |
